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Abstract
Background: This article sets out a framework for measurement of quality of care relevant to enhanced recovery
pathways (ERPs) in elective colorectal surgery. The proposed framework is based on established measurement
systems and/or theories, and provides an overview of the different approaches for improving clinical monitoring,
and enhancing quality improvement or research in varied settings with different levels of available resources.
Methods: Using a structure-process-outcome framework, we make recommendations for three hierarchical tiers of
data collection.
Discussion: Core, Quality Improvement, and Best Practice datasets are proposed. The suggested datasets incorporate
patient data to describe case-mix, process measures to describe delivery of enhanced recovery and clinical outcomes.
The fundamental importance of routine collection of data for the initiation, maintenance, and enhancement of
enhanced recovery pathways is emphasized.
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Background
Enhanced recovery pathways (ERPs) are a structured ap-
proach to improving the quality of perioperative patient
care, typically in the setting of elective major surgery.
ERPs comprise a list of best practice recommendations
throughout the patient pathway, which, when consist-
ently applied, result in improved patient outcome. The
unifying aim of ERPs is to minimize the physiological
disturbance associated with major surgery and promotion
of behaviors that will accelerate the recovery process.
Successful evaluation of such quality improvement or re-
search endeavors is critically dependent on careful selec-
tion of the measures used for evaluation. At first glance,
this statement may seem disingenuous; if a treatment
“works,” then surely this will be evident irrespective of the
measure by which success is judged. However, ERPs may
be considered a “complex intervention” where multiple
stakeholders (including patients) must work together to
achieve full implementation of the prescribed pathway. As
with all complex interventions, therefore, it is important
to evaluate compliance as well as outcome, as this may
provide valuable insight into why some centers may
achieve better outcomes than others (Moonesinghe 2016).
* Correspondence: timothy.miller2@duke.edu
†Equal contributors
6Department of Anesthesiology, Duke University Medical Center, Durham,
North Carolina, USA
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Moonesinghe et al. Perioperative Medicine  (2017) 6:6 
DOI 10.1186/s13741-017-0062-7
This is particularly pertinent in light of evidence which
suggests that there is a “dose response” effect between in-
creasing compliance with specific ERP elements and re-
duced length of stay in hospital (Simpson et al. 2015).
Further, the use of unvalidated and inappropriately applied
outcome measures risks both over- and/or underestima-
tion of therapeutic effect in clinical studies (Pearse et al.
2014). Finally, when the evidence supports implementa-
tion at scale, poorly selected outcome measures may lead
to a loss of belief and resilience in quality improvement
initiatives, which may ultimately risk undermining clinical
engagement and effectiveness. The aim of this manuscript
is to provide recommendations for the evaluation of ERP
implementation and to describe the process by which
these recommendations were reached.
Methods
On March 4–5, 2016, the first Perioperative Quality Initia-
tive (POQI-1) was held in Durham, North Carolina (Miller
et al. 2016). A group of international experts was estab-
lished, including viewpoints representing anesthesiology,
surgery, and nursing. The group was divided into four work-
groups focused on specific topics related to colorectal sur-
gery within an ERP. In this workgroup, experts were asked
to set out a framework for measurement of quality of care.
POQI-1 was a consensus building conference designed
around a modified Delphi process in which the group al-
ternately convened for plenary discussion sessions and
then retired for small group discussion (Miller et al.
2016). Over 2 days, consensus was reached around the
main issues within each topic. The group chairs and co-
chairs were responsible for leading the discussions and
summarizing the group topic discussions, recommenda-
tions, and suggestions for future research.
Discussion
Taxonomy of measures
In order to fully evaluate an ERP, quality measures should
include all aspects of the program as categorized according
to Donabedian’s Quality of Care Framework: i.e., structure,
process, and outcome model (Donabedian 1966). Structure
refers to organizational context, both “hard” features (e.g.,
medical equipment, pharmacy budgets, staffing schedules)
and “soft” or cultural factors (i.e., organizational leadership,
staffing incentives, team interactions and behaviors).
Organizational context may be further divided according to
levels of enquiry when conducting evaluations—macro (na-
tional or international policy), meso (institutional or re-
gional), or micro (clinical teams). Process refers to the
series of actions or steps in the delivery of care. Each of the
elements of an ERP is a process that may be measured or
recorded. Outcome measures should capture the result of
the intervention. Candidate outcomes include patient-
reported surveys (e.g., health-related quality of life,
satisfaction, quality of recovery), objective and patient-
centered measures (e.g., complications, mortality), mea-
sures of resource use (e.g., length of hospital or critical care
stay), or economic measures (e.g., incremental cost-
effectiveness ratio). Measurement of patient factors for the
purposes of case-mix adjustment or comparison of baseline
characteristics should also be considered.
In the context of a clinical trial of an ERP (or an indi-
vidual ER element), both process and outcome should
be measured. If, as should always be the case with clin-
ical trials of efficacy or effectiveness, there are sufficient
resources available to ensure that the treatment (in this
case, the pathway) is delivered according to a study
protocol, then an “intention-to-treat” analysis may be
adopted, with important information derived from meas-
uring protocol deviations to contextualize the outcomes.
In the case of a quality improvement (QI) initiative,
process measures are likely to be of most use in driving
change, but all three domains of structure, process, and
outcome should be evaluated.
What data should be collected?
Choice of data to be collected will be dependent on the
setting, the aim (research vs. quality improvement), and
the available resources, including staffing and technology.
Research
The challenge of inconsistent use of outcome measures
in clinical studies has driven two major international
initiatives, which will be reporting in 2016–2017.
COMPAC (Core Outcome Measures for Perioperative
and Anaesthesia Care; http://comet-initiative.org/stud-
ies/details/632?result=true) has arisen from the COMET
(Core Outcome Measures for Effectiveness Trials)
initiative (www.comet-initiative.org) which aims to
identify the “vital few” outcomes which should be mea-
sured in all studies, irrespective of the primary aim or
outcome, so that outcomes from different studies can be
compared, contrasted, and combined (e.g., within meta-
analyses). A parallel endeavor, StEP (Standardized
Endpoints in Perioperative care), will develop recommen-
dations about how different outcomes should be defined
and analyzed in clinical trials. Both initiatives will focus
predominantly on clinical trials, rather than epidemiology
or QI, but it is likely that their recommendations will be
of relevance, at least in part, in other settings. Both these
initiatives will cover the full range of outcome measures
discussed above, and are using systematic reviews followed
by Delphi consensus methods to select and define relevant
measures (Myles et al. 2016).
The POQI initiative awaits the results of these initia-
tives as their recommendations will be evidence based,
and the ambition is that researchers, peer reviewers, and
journal editors embrace them. For now, we will therefore
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turn to the general principles of process and outcome
measures which could be used in QI and research
initiatives.
Measurement for improvement
Our recommendations for measurement have three tiers,
which are sensitive to the resources available to local
hospitals (Fig. 1). The Core dataset comprises almost en-
tirely of routine administrative data and should be easily
recordable from routine hospital data collection pro-
cesses; therefore, it should be possible for all hospitals
implementing colorectal ERPs to record these variables.
The Quality Improvement dataset is much more com-
prehensive, but in keeping with the principles of meas-
urement for improvement (Peden and Moonesinghe
2016), we recommend that this dataset is collected at
regular intervals throughout the year on a sample of pa-
tients (perhaps 20% per year) so that variation in pro-
cesses can be tracked. Finally, the Best Practice dataset is
a comprehensive measurement and monitoring system
that all hospitals may aspire to use. The collection of this
dataset would likely require both technological support
(e.g., electronic health record systems) and personnel sup-
port (e.g., surgical case reviewers as used in the National
Surgery Quality Improvement Program (NSQIP)).
For each category of measure, we have provided a
justification for the type of measure, a discussion
about the issues (including evidence base) for each
option, and finally our recommendations according to
the three tiers described above.
Process measures
Justification for inclusion
ERPs are essentially a series of processes, and com-
pliance with these processes can be used to drive
quality improvement initiatives. Compliance with in-
dividual processes can be tracked over time (using
run charts, e.g., percent use per month) and the na-
ture of observed variation analyzed using statistical
process control, to differentiate between common
cause, or “natural” variation in the system, or special
cause, i.e., unpredictable variation which requires in-
vestigation (Peden and Moonesinghe 2016). For ex-
ample, if preoperative prescription of a gabapentinoid
for analgesia is part of your ERP, and use of this
medication drops from 90 to 30%, then there may be
an explanation for the change in use that needs to be
explored further.
Measurement considerations including choice of measures
Recent work in the UK found a modest “dose response”
effect between increased compliance with ERP elements
and reduced length of hospital stay (Simpson et al.
2015). In keeping with the principles of industrial effi-
ciency, high reliability (>80 or 90% of patients fully com-
pliant) is required to effect improvement in outcomes.
Fig. 1 Measurement matrix for colorectal enhanced recovery pathways
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Thus, one could argue that external reporting of ER pro-
cesses, for example, for the purposes of comparison be-
tween teams or providers, could be as succinct as simply
reporting the binary indicator of whether >80% of pa-
tients received all elements of the locally approved ERP.
However, by measuring individual elements, particularly
those that are more challenging to implement (in UK
practice, this has generally been preoperative carbohy-
drate loading), valuable information can be obtained for
quality improvement purposes.
There may be some merit in considering ERPs as care
bundles. While most ERPs are not bundles in the trad-
itional sense (as the number of elements within an ERP
usually exceeds the recommended three to five) (Resar
et al. 2012), there are similarities, which are worthy of
note, and raise considerations about how compliance
data should be collected. There may be a tendency for
clinicians to focus on the individual elements of a path-
way or bundle, when contemplating whether implemen-
tation may be beneficial to their patients. However,
while each element should be evidence based, it is the
package, which should be the focus, rather than the indi-
vidual interventions. The aim should be to implement
all elements unless there is a medical contraindication,
and take this as the measure of compliance (in bundle
terminology—the “all or none” or AON approach)
(Borgert et al. 2015).
Two further points require consideration. A recent
systematic review of 50 papers relating to colorectal
ERPs (Day et al. 2015) found that the level of detail re-
garding ER processes was generally insufficient to pro-
mote knowledge transfer. If a study either reports
percentage compliance or uses the “all or none” ap-
proach, rather than reporting compliance with individual
elements, it remains important that manuscripts provide
detail about the pathway’s constituent measures. Finally,
clinical experience and published evidence would sug-
gest that some interventions have been straightforward
to implement (e.g., in the UK, avoidance of sedative pre-
medication) and others considerably more challenging
(e.g., preoperative carbohydrate loading) (Simpson et al.
2015). This observation fits neatly within the Normalization
Process Theory—that for a QI intervention to be successful,
it should be coherent and encourage cognitive participation,
collective action, and reflexive monitoring (May et al. 2009).
When a QI intervention is evaluated as having achieved
these four aims, it may be deemed to have reached its objec-
tive—that is, the process has been fully implemented and
thus “normalized”. One may propose, therefore, that if an
individual ER element has become so embedded that it is
routine, the requirement for formal measurement may have
subsided. For example, there would be little value in spend-
ing resources on measuring rates of capnography monitor-
ing during surgical anesthesia, as this is a “normalized”
process. While normalization is not necessarily irreversible,
and thus some vigilance (“reflexive monitoring”) may
be required to ensure that pre-implementation prac-
tice does not creep back in, omitting unnecessary
process measures from data collection may renew
clinical focus, enable more cost and clinically effective
monitoring and QI, and, ultimately, enable a move
more towards the optimal “bundled” approach to
implementation.
Recommendations
Core dataset
Patient-level data on entry into a colorectal enhanced re-
covery pathway should be recorded for the purpose of
national monitoring of engagement with ER. The sim-
plest approach would be to report the proportion of pa-
tients in an institution that are enrolled on an ERP. In
institutions where patients are selected for enrolment
into ERPs, as opposed to an ERP being routine practice,
recording the reason for non-ERP enrolment may also
be of value.
Quality Improvement dataset
Measuring compliance with individual elements of
ERPs is important for systems monitoring. However,
for quality improvement (QI) purposes, continuous
measurement on a convenience sample of patients
may be sufficient and can be implemented with less
investment of resources than would be required for
routine monitoring.
We recommend that in a sample of patients (at least
20% of annual total), compliance with individual ER ele-
ments is tracked and monitored. Participation in out-
come monitoring programs such as NSQIP may
facilitate this practice. Ideally, these data should be re-
corded on run charts to facilitate tracking compliance
over time. At the beginning of implementing an ERP,
compliance with all elements of the pathway in a sample
of patients should be the aim. Over time, if some ele-
ments have consistent 100% compliance, local teams
may consider removing these data items, as implementa-
tion has been “normalized”; at this point the focus of im-
provement efforts should shift to areas with poorer
compliance.
Best Practice dataset
In hospitals where electronic health records have been
introduced or there is institutional participation in out-
come monitoring programs, it should be possible to rec-
ord a detailed process measure dataset on all patients.
Thus, best practice in process measurement, which all
institutions should strive towards, is complete collection
of ER compliance data, on all patients undergoing colo-
rectal surgery, irrespective of whether they have been
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enrolled in an ERP or not. This level of data capture
would facilitate both quality improvement and subse-
quent clinical research.
Clinical outcomes
Risk adjustment
Justification for inclusion
Comparison of outcomes over time or between teams or
institutions would benefit from risk/case-mix adjustment
or at least comparison of patient risk factors. This en-
ables teams to understand outcomes in the context of
their patients’ comorbidities and other risk factors, so
enabling meaningful comparisons and avoiding the
risk of biased patient selection that enhances the
treatment effect.
Measurement considerations including choice of measures
Comparison of baseline characteristics to demonstrate
the similarities or differences between populations being
compared could be as simple as a basic measure of func-
tional status (e.g., the American Society of Anesthesiolo-
gists’ Physical Status Score, ASA-PSS), patient age,
procedure name, and particularly if long-term outcomes
are being compared, patient gender. Such data can pro-
vide baseline information without the need for regres-
sion analyses required for risk adjustment.
A systematic review of risk prediction/adjustment
measures validated in heterogeneous perioperative popu-
lations evaluated the literature from 1980 to 2011 and
concluded that the Portsmouth-Physiology and Opera-
tive Severity Score for the enUmeration of Mortality
(P-POSSUM) and the Surgical Risk Scale were the most
consistently accurate tools that have been validated in
multiple studies; however, both have limitations (Moone-
singhe et al. 2013). POSSUM-related tools have been
evaluated in a further systematic review in colorectal
cancer surgery and, again, P-POSSUM was favored
(Richards et al. 2010). An advantage of POSSUM-related
tools is their non-proprietary “open source” status—the
models are published, enabling any healthcare system
which has sufficient resources to collect and analyze
their data using this model to adjust risk. However, this
openness combined with a fixed model also presents a
problem. It is not surprising that a risk model’s accuracy
(particularly calibration) will vary over time, as changes
in standards of care and the epidemiology of patient
health will also change. Therefore, ideally, bespoke
models would be developed which can be updated (reca-
librated and discrimination re-checked) on regular basis.
The NSQIP system does this; however, as the model
is not published, it is not possible for other health-
care systems to use it, or validate it on their popula-
tions, unless a subscription is paid to enter the
program. Nevertheless, the dataset is well known and
other systems may therefore chose to collect the con-
stituent variables.
Recommendations
Core dataset
Age, gender, ASA-PS score, and surgical procedure
name should be recorded on all patients, so that these
basic demographic data can be compared between
populations.
QI dataset
In a sample of patients (at least two per week) in whom
compliance and outcome data are also collected, a vali-
dated composite measure of risk should be recorded.
For hospitals enrolled in the NSQIP monitoring pro-
gram, this should be simply the NSQIP dataset. For hos-
pitals not enrolled in this system, we recommend the
Colorectal-POSSUM model. Over time, inter-institutional
data sharing would enable bespoke models for colorectal
surgery to be generated for US healthcare.
Best Practice dataset
A comprehensive risk-adjustment measure should be in-
cluded on all patients. As above, this should be the
NSQIP variables for hospitals participating in that pro-
gram, or the Colorectal-POSSUM elements for those
outside the NSQIP system.
Postoperative morbidity or complications
Justification for inclusion
Short-term (inpatient) postoperative complications
may have substantial impact on longer-term survival
(Khuri et al. 2005; Moonesinghe et al. 2014) and
quality of life (Pinto et al. 2016). They also carry sub-
stantial cost to the healthcare system (Eappen et al.
2013; Healy et al. 2016).
Measurement considerations including choice of measures
Complications may be measured individually (e.g., pneu-
monia) or as composite measures (e.g., Clavien-Dindo
grading (Clavien et al. 1992; Clavien and Strasberg 2009)
or the Postoperative Morbidity Survey (Clavien and
Strasberg 2009)). A recent systematic review of colorec-
tal ERPs (Day et al. 2015) found that morbidity was the
most commonly measured outcome (98%), followed by
length of stay (94%) and mortality (90%).
Even in studies where individual organ-specific compli-
cations are recorded (e.g., any study within the NSQIP or
Veterans’ Affairs (VA) systems), unless a particular organ-
specific outcome is of particular interest (e.g., respiratory
outcomes in studies of ventilator-associated pneumonia
bundles), many studies report composites of “all complica-
tions” or “major complications” (Abedi et al. 2009;
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Acott et al. 2009; Al-Refaie et al. 2010; Bush et al.
2009; Hamel et al. 2005).
Recommendations
Core dataset
The collection of postoperative complications data may
be too onerous for smaller providers, those without ac-
cess to electronic health records or with limited re-
sources. Therefore, we recommend that outcomes are
recorded using alternate means (see under “Resource
use and economic outcomes”).
QI dataset
Process measures that may be used as a surrogate of
outcome include the DREAM measures: drinking, eat-
ing, analgesia, mobilizing, and sleeping (Levy et al.
2016). Early attainment of these goals should be consid-
ered to be markers of successful ERP. We recommend
that hospitals record a point prevalence estimate of
DREAM on day 1 postoperatively while patients remain
in hospital, in the same sample of at least two patients
per week. While this has yet to be formally validated,
this measure has face validity, is a pragmatic measure
which requires little resource to implement, and is
patient-centered.
Best Practice dataset
Hospitals participating in outcome monitoring programs
which include measures of morbidity or complications
should review results on all patients undergoing colorec-
tal surgery, using these data (with risk adjustment) to
monitor local outcomes and compare against other simi-
lar providers. Such measures may include the NSQIP
complication dataset, the validated Postoperative Mor-
bidity Survey recorded on a particular day (e.g., day 7
following surgery) (Bennett-Guerrero et al. 1999;
Grocott et al. 2007), and the Clavien-Dindo scoring sys-
tem (Clavien et al. 2009) which is an estimate of the se-
verity of deviation from an uncomplicated postoperative
course recorded at the time of discharge from hospital.
Patient satisfaction, patient experience, and patient-
reported outcome measures (including health-
related quality of life and disability-free survival)
Justification for inclusion
The importance of understanding outcome from the pa-
tient perspective to be able to ascertain quality and value
of healthcare is acknowledged by patients, providers,
and funders.
Modern therapies, particularly those administered on
the critical care unit, mean that many patients who may
not previously have survived a complicated postoperative
course may now leave hospital, sometimes after pro-
longed stay (beyond 30 days); survivors are also at risk
of longer-term sequelae, both physical (Khuri et al. 2005;
Moonesinghe et al. 2014; Toner and Hamilton 2013)
and psychological (Wade et al. 2012; Wade et al. 2013;
Wade et al. 2014; Wade et al. 2015). Thus, short-term
survival, while an important metric, does not provide a
comprehensive assessment of outcome, particularly from
the patient perspective. Therefore, a measure of quality
of life or functional status should ideally be administered
to help contextualize survival/mortality.
Measurement considerations including choice of measures
Measures that are completed by patients rather than
staff may include patient satisfaction, patient experience,
quality of recovery, or patient-reported outcomes.
Patient experience measures have been developed in dif-
ferent healthcare systems to meet the particular needs of
those patient populations and organizational interests;
they measure the patients’ views on the whole service
experience, including staff behaviors, efficiency of transit
through the hospital, and quality of care. Patient satisfac-
tion measures with anesthesia care have been systemat-
ically reviewed and their development and validity
formally assessed—a list of recommendations for differ-
ent settings was produced (Barnett et al. 2013). Such
measures may be particularly important in the very short
term (e.g., within 24 h of surgery, or even before dis-
charge from the recovery ward).
Patient-reported outcomes may be assessed in the
short term (for example, the first few days or weeks fol-
lowing surgery) using quality of recovery scores. These
measure patients’ symptoms and deviation from usual
basic activities such as mobilization and sleeping.
Australian researchers have developed a series of quality
of recovery scores (Myles et al. 1999; Myles et al. 2000;
Stark et al. 2013; Royse et al. 2010) that have been vali-
dated and systematically reviewed (Gornall et al. 2013).
Finally, patient-reported outcome measures (PROMs)
evaluate health-related quality of life before and after an
intervention, and the difference is taken as a measure of
the success (or otherwise) of the procedure. The post-
procedure measurement is typically recorded 6 months
or 1 year after surgery, both generic (e.g., the EQ-5D)
and condition/procedure-specific PROMs have been de-
veloped and validated. The EQ-5D is a five-domain
measure that includes questions for patients about pain,
mood, mobility, ability to self-care, and ability to under-
take their usual activities. The EQ-5D may also be used
in health economic evaluations (see later). The interpret-
ation of health-related quality of life (HRQOL) question-
naires may be subject to some selection bias (completion
rates for follow-up questionnaires vary with patient age,
socio-demographic status, and ethnicity); nevertheless,
they are valid composite measures of outcome and soci-
etal cost effectiveness.
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The World Health Organization’s Disability Assess-
ment Schedule v2.0 (WHODAS 2.0) has recently been
validated in a heterogeneous sample of perioperative pa-
tients, of whom approximately a third had “general” sur-
gery (Shulman et al. 2015). The WHODAS was found to
be valid and acceptable to patients; it covers both phys-
ical and emotional domains in more detail than the EQ-
5D. It has yet to be validated in other surgical settings.
Recommendations
Core and QI datasets
A basic measure of patient experience such as the
Agency for Healthcare Research and Quality CAHPS
consumer satisfaction survey (Vetter et al. 2013) is rec-
ommended for all patients or at least for the sample that
are having other outcomes reported (QI dataset).
Best Practice dataset
Administration of a validated health-related quality of
life questionnaire such as the EQ-5D or SF-36 before
surgery and at 1 year postoperatively is recommended.
The WHO Disability Assessment Schedule v2.0 has been
validated for use in the perioperative population
(Shulman et al. 2015); this may provide an important
alternative, enabling the measurement of “disability-
free survival” at 1 year, but currently has a less com-
prehensive literature supporting its use.
Resource use and economic outcomes
Justification for inclusion
Health economic measures are an essential component
of a comprehensive outcome framework if the delivery
of healthcare is to be efficient in relation to the re-
sources allocated to it. Health economics is “the science
that studies human behavior as a relationship between
ends and scarce means that have alternative uses” within
the context of healthcare (Robbins 1932). One aim of
such study is to quantify value, defined as achieving the
best possible benefit per unit cost, in order to drive the
efficient use of the limited financial resources supporting
a healthcare system, whatever the overall system of fi-
nancial flows within that system. There is an important
distinction between price, a transactional concept
dependent on an agreed exchange of money between a
customer and a provider, and value, which is defined by
the customers’ perception of benefit. A variety of defini-
tions of value may be used to characterize the relation-
ship between costs and benefits, but in the healthcare
setting, all are limited by the difficulty of attributing a
monetary value to a health benefit. Several approaches
have been adopted to describe value in healthcare in-
cluding cost-effectiveness analysis, cost utility analysis,
and incremental cost-effectiveness ratios (ICERs). A
more detailed introduction to these methods is available
elsewhere in the perioperative literature (Grocott and
Mythen 2015). In the US setting, the recent change from
fee-for-service reimbursement to “bundled payments”
has been driven by a desire to constrain healthcare ex-
penditure and improve value.
Measurement considerations including choice of measures
Length of stay (LOS) is one the most commonly used
measures in studies of ERPs, due to face validity and
ease of measurement; further, reducing length of stay
(and therefore by implication complications, and as a re-
sult costs) has traditionally been one of the key per-
ceived benefits of ERPs. However, there remain
limitations in measurement of LOS: variation in how
length of stay is measured may impact comparisons,
LOS may be affected by factors other than quality of
perioperative care (e.g., occupational therapy or social is-
sues), and as a surrogate for a true economic analysis of
costs, it performs poorly, as there is usually a decrement
in non-fixed costs as a patient recovers but remains in
hospital. When analyzing length of stay data for a
population, the data are likely to be skewed by a few
long-stay patients. Therefore, while median LOS may
be the most statistically appropriate population esti-
mate and the most representative of what most pa-
tient’s experience, mean LOS should also be reported,
in order to provide a fuller picture of the total costs
associated with a service.
The number of postoperative days alive and out of
hospital within a limited time frame (e.g., 60 days), collo-
quially known as “happy days”, is a measure that com-
bines both length of stay (important as a surrogate of
complications) and survival. A patient who died in hos-
pital on day 2 postoperatively and a patient who had a
complicated postoperative course and a 75-day LOS
would both have zero happy days. Such measures avoid
the misleading recording of an early postoperative death
as a short length of stay.
Quality of life measures are discussed in more detail
above. Health economic evaluations commonly incorp-
orate the notion of “quality-adjusted life years” (QALYs)
where 1 QALY is a year in perfect health: QALY dis-
counts survival based on quality of life measured using
measures such as EQ-5D. A key consideration for
health economic analyses is the time frame over
which such measures are made. Benefits of surgery
may be manifest for many years after the operation
and the durability of QoL improvements will have a
significant impact on the cost-effectiveness evaluation
if a QALY-based analysis is used.
Hospital costs assess the monetary cost of ERPs and
rise with increased length of stay and complicated post-
operative courses. In a bundled payment environment,
costs will be balanced against provider reimbursements
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to calculate healthcare facility profits or losses (Healy et
al. 2016; Dimick et al. 2004). A variety of methods may
be used to account for costs within a healthcare institu-
tion but the general trend has been towards activity-
based costing (ABC), an approach which aims to
attribute the true costs of any activity to that activity
(including direct costs and indirect costs or overheads).
Patient-level costing is specific healthcare example of
ABC that has long been used in multi-payer healthcare
systems (e.g., the USA) but only relatively recently
adopted in “single-payer” nationally funded systems (e.g.,
NHS in England). ABC offers the potential for inter-
national comparisons of the cost effectiveness of health-
care at a patient or institutional level, but unfortunately,
such analyses are currently challenging in the absence of
internationally agreed standards for ABC.
Recommendations
Core and QI datasets
Length of hospital stay is usually routinely measured,
and therefore, we recommend that this is recorded for
all patients undergoing colorectal surgery. Both median
(and range) and mean (and standard deviation) should
be reported.
Best Practice dataset
Hospital costs should be recorded for all patients under-
going surgery, ideally using a recognized method of
ABC, to enable comparison between the patient popula-
tions who have complicated and uncomplicated postop-
erative stays. Postoperative days alive and out of hospital
(“happy days”, with an endpoint of 60 days) should be
recorded for all patients. A measure of health-related
quality of life (e.g., the EQ-5D or the SF-36) should also
be recorded preoperatively and at 6 months and 1 year
postoperatively, to facilitate calculation of quality-
adjusted life years (QALYs).
Conclusion
This article sets out a framework for measurement of
quality of care relevant to enhanced recovery pathways
(ERPs) in elective colorectal surgery. We have proposed
three hierarchical tiers of data collection: core, quality
improvement, and best practice. Each dataset is based
on a structure-process-outcome framework of quality
description. The relevant data collection tier will depend
on the resources available and level of engagement
within a particular institution. The suggested datasets in-
corporate patient data to describe case-mix, process
measures to describe delivery of enhanced recovery
pathways and clinical outcomes. The fundamental im-
portance of routine collection of data for the initiation,
maintenance, and enhancement of enhanced recovery
pathways is emphasized.
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